A breakthrough combination medication designed for the effective management of heart failure. AZMAWELL50 combines two powerful active ingredients, Sacubitril and Valsartan, in a single, convenient tablet to help improve heart function and patient outcomes.

Key Benefits

• Dual-Action Power: Uniquely formulated to simultaneously suppress harmful neurohormonal systems and enhance protective pathways in the heart.

• Proven Efficacy in Heart Failure: Clinically shown to reduce the risk of cardiovascular death and hospitalization for heart failure.

• Enhanced Quality of Life: Helps patients breathe easier and engage in daily activities with less fatigue.

• Convenient Dosage: A single tablet simplifies treatment regimens, improving patient adherence.

Indications

• Treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adults.

• Used to replace an ACE inhibitor or an angiotensin II receptor blocker (ARB) under physician guidance.

• Part of a comprehensive heart failure management program.

Possible Side Effects:

Some patients may experience dizziness, lightheadedness, hyperkalemia (high potassium), cough, or renal impairment. It is important to have regular blood tests to monitor kidney function and potassium levels. A rare but serious side effect can be angioedema (swelling of the face, lips, throat). Patients should report any unusual symptoms to their healthcare provider immediately.

Product Specifications

• Brand Name: AZMAWELL 50

• Composition: Sacubitril and Valsartan

• Dosage Form: Film-Coated Tablets

• Available Strengths: 50mg

• Manufacturer: Nextwell Pharmaceuticals

AZMAWELL 50 – Empowering hearts for a stronger tomorrow.

The post AZMAWELL 50 SACUBITRIL AND VALSARTAN TABLETS appeared first on nextwell.

A high-strength breakthrough combination medication designed for the effective management of heart failure. AZMAWELL 100 combines two powerful active ingredients, Sacubitril and Valsartan, in a single, convenient tablet to help improve heart function and patient outcomes.

Key Benefits

• Enhanced Dual-Action Power: Provides stronger suppression of harmful neurohormonal systems and enhanced protective pathways in the heart.

• Superior Efficacy in Heart Failure: Clinically proven to significantly reduce the risk of cardiovascular death and hospitalization for heart failure.

• Improved Quality of Life: Enables patients to breathe easier and engage in daily activities with reduced fatigue.

• Optimal Convenience: Higher strength allows for simplified treatment regimens, improving patient adherence.

Indications

• Treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adults requiring higher dosage

• Replacement therapy for ACE inhibitors or angiotensin II receptor blockers (ARB) under physician supervision

• Integral component of a comprehensive heart failure management program

Possible Side Effects

Some patients may experience dizziness, lightheadedness, hyperkalemia (high potassium levels), mild cough, or renal impairment. Regular blood tests are essential to monitor kidney function and potassium levels. In rare cases, angioedema (swelling of the face, lips, or throat) may occur. Patients should immediately report any unusual symptoms to their healthcare provider.

Product Specifications

• Brand Name: AZMAWELL 100

• Composition: Sacubitril and Valsartan

• Dosage Form: Film-Coated Tablets

• Available Strengths: 100mg

• Manufacturer: Nextwell Pharmaceuticals

AZMAWELL 100 – Advanced cardiac care for a stronger heart and a better life.

The post AZMAWELL 100 SACUBITRIL AND VALSARTAN TABLETS appeared first on nextwell.